Open AccessManagement of Generalized Anxiety Disorder in Primary Care
Author(s) -
Jonathan Davidson,
Douglas E. Feltner,
A. Dugar
Publication year - 2010
Publication title -
primary care companion to the journal of clinical psychiatry
Language(s) - English
Resource type - Journals
eISSN - 1537-6699
pISSN - 1523-5998
DOI - 10.4088/pcc.09r00772blu
Subject(s) - quetiapine , generalized anxiety disorder , escitalopram , psychiatry , risperidone , medicine , olanzapine , anxiety , buspirone , duloxetine , venlafaxine , epidemiology , psychology , clinical psychology , schizophrenia (object oriented programming) , alternative medicine , receptor , pathology , antidepressant , agonist
Generalized anxiety disorder (GAD) is one of the most common psychiatric disorders in primary care, although it is often underrecognized and undertreated. GAD is chronic, disabling, and associated with other health problems. Treatment response is often unsatisfactory, but the clinical evidence base for new treatments has expanded substantially in the past decade and suggests a growing range of options for reducing the burden of GAD. The objective of this article was to review current literature on GAD and its management to provide an overview of the clinical importance of GAD in primary care and available treatments.